Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218). [electronic resource]
Producer: 19981231Description: 451-61 p. digitalISSN:- 1077-9450
- AIDS Vaccines -- administration & dosage
- Adolescent
- CD4 Lymphocyte Count
- Child
- Child, Preschool
- Cohort Studies
- Disease Progression
- Double-Blind Method
- Female
- HIV Envelope Protein gp120 -- immunology
- HIV Envelope Protein gp160 -- immunology
- HIV Infections -- immunology
- Humans
- Immunoenzyme Techniques
- Immunotherapy, Active -- adverse effects
- Infant
- Injections, Intramuscular
- Lymphocyte Activation
- Male
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.